Statins and Breast Cancer Prevention: Time for Randomized Controlled Trials
- 1 May 2006
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (13), 2129-2130
- https://doi.org/10.1200/jco.2005.05.5392
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Use of Statins and Breast Cancer: A Meta-Analysis of Seven Randomized Clinical Trials and Nine Observational StudiesJournal of Clinical Oncology, 2005
- Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanismCarcinogenesis: Integrative Cancer Research, 2004
- Statin use and the risk of breast cancerJournal of Clinical Epidemiology, 2003
- Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro studyCarcinogenesis: Integrative Cancer Research, 2001
- Hydrophilicity/ lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitorsTrends in Pharmacological Sciences, 1998
- Stimulation of Human Breast Cancer MCF-7 Cells with Estrogen Prevents Cell Cycle Arrest by HMG-CoA Reductase InhibitorsBiochemical and Biophysical Research Communications, 1996